Cargando…
MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor
MicroRNAs (miRs) have been demonstrated to play key roles in the development and progression of hepatocellular carcinoma (HCC). However, the regulatory mechanism of miR-503 in HCC has not been fully uncovered. In this study, we found that miR-503 was significantly downregulated in HCC tissues compar...
Autores principales: | Xiao, Yao, Tian, Qinggang, He, Jiantai, Huang, Ming, Yang, Chao, Gong, Liansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913972/ https://www.ncbi.nlm.nih.gov/pubmed/27366090 http://dx.doi.org/10.2147/OTT.S106351 |
Ejemplares similares
-
Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis
por: Huang, Ming-Zhi, et al.
Publicado: (2020) -
MiR‐497‐5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin‐like growth factor 1
por: Xu, Guo‐shu, et al.
Publicado: (2019) -
ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro
por: Tan, Guangxing, et al.
Publicado: (2020) -
MiR‐497‐5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin‐like growth factor 1
Publicado: (2022) -
TGF-β1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells
por: Guo, Pin, et al.
Publicado: (2017)